Michele Potashman

Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019

Emma Nichols, Jaimie D Steinmetz, Kai Fukutaki et al. · The Lancet Public Health · 2022 · 5.1K citations · Full text

Medicine, Geriatric Medicine, Neurology +15

Design, Synthesis, and Evaluation of Orally Active Benzimidazoles and Benzoxazoles as Vascular Endothelial Growth Factor-2 Receptor Tyrosine Kinase Inhibitors

Michele Potashman, James Bready, Angela Coxon et al. · Journal of Medicinal Chemistry · 2007 · 167 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +16

Discovery and Optimization of Triazolopyridazines as Potent and Selective Inhibitors of the c-Met Kinase

Brian K. Albrecht, Jean-Christophe Harmange, David Bauer et al. · Journal of Medicinal Chemistry · 2008 · 139 citations · Full text

Medicine, Medicinal Chemistry, Oncology +14

Naphthamides as Novel and Potent Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitors: Design, Synthesis, and Evaluation

Jean-Christophe Harmange, Matthew M. Weiss, Julie Germain et al. · Journal of Medicinal Chemistry · 2008 · 70 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +14

Discovery and optimization of potent and selective triazolopyridazine series of c-Met inhibitors

Alessandro A. Boezio, Loren Berry, Brian K. Albrecht et al. · Bioorganic & Medicinal Chemistry Letters · 2009 · 56 citations · Full text

Pharmacy, Chemistry, Medicinal Chemistry +13